TUBERCULOSIS DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Tuberculosis Drugs Market, By Therapy Type (First Line Therapy, and Second Line Therapy), By Disease type (Active TB, and Latent TB), By End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In: 19 Jan, 2026
Code: CMI191
Page number: 151
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Table of Contents (Version-2026)

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Therapy Type
  - Market Snippet, By Disease Type
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Landscape
- Drug Recall
- Porter’s Five Forces Model
Global Tuberculosis Drugs Market, By Therapy Type, 2026 – 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2017 – 2033
  - Segment Trends
- First Line Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn)
    - Isoniazid (INH)
    - rifampicin (RIF)
    - Ethambutol (EMB)
    - Pyrazinamide (PZA)
    - Streptomycin (SM).
- Second Line Therapy
  - Fluoroquinolones
  - Injectable antituberculosis drugs
Global Tuberculosis Drugs Market, By Disease Type, 2026 – 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2017 – 2033
  - Segment Trends
- Active TB
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn)
- Latent TB
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn)
Global Tuberculosis Drugs Market, By Distribution Channel, 2026 – 2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2017 – 2033
  - Segment Trends
- Hospital Pharmacy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn)
- Retail Pharmacy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn)
- Online Pharmacy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Bn)
Global Tuberculosis Drugs Market, By Region, 2026 – 2033, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, By Region, 2018– 2033
  - Regional Trends
- North America
  - Market Size and Forecast, By Therapy Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Disease Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2026 – 2033, (USD Bn)
    - U.S.
    - Canada
- Europe
  - Market Size and Forecast, By Therapy Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Disease Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2026 – 2033, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Therapy Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Disease Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2026 – 2033, (USD Bn)
    - China
    - Japan
    - India
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Market Size and Forecast, By Therapy Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Disease Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2026 – 2033, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Africa
  - Market Size and Forecast, By Therapy Type 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Disease Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Country/Region, 2026 – 2033, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
- Middle East
  - Market Size and Forecast, By Therapy Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Disease Type, 2026 – 2033, (USD Bn)
  - Market Size and Forecast, By Country, 2026 – 2033, (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
Competitive Landscape
- Company Profiles
  - Lupin ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Johnson & Johnson Services, LLC
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Macleods Pharmaceuticals Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Otsuka Pharmaceutical Co., Ltd.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us and Sales Contact

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now